CN105146267A - Composition with weight losing function and application thereof - Google Patents
Composition with weight losing function and application thereof Download PDFInfo
- Publication number
- CN105146267A CN105146267A CN201510523739.5A CN201510523739A CN105146267A CN 105146267 A CN105146267 A CN 105146267A CN 201510523739 A CN201510523739 A CN 201510523739A CN 105146267 A CN105146267 A CN 105146267A
- Authority
- CN
- China
- Prior art keywords
- parts
- composition
- weight
- losing function
- green
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 32
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 19
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 19
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 19
- 241000533293 Sesbania emerus Species 0.000 claims abstract description 19
- 235000020688 green tea extract Nutrition 0.000 claims abstract description 19
- 229920001100 Polydextrose Polymers 0.000 claims abstract description 17
- 235000013856 polydextrose Nutrition 0.000 claims abstract description 17
- 229940069765 bean extract Drugs 0.000 claims abstract description 13
- 229940094952 green tea extract Drugs 0.000 claims abstract description 13
- 239000000284 extract Substances 0.000 claims abstract description 8
- 150000001480 arabinoses Chemical class 0.000 claims description 6
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 claims description 4
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 claims description 4
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 claims description 4
- 229940074393 chlorogenic acid Drugs 0.000 claims description 4
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 claims description 4
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 claims description 4
- 235000001368 chlorogenic acid Nutrition 0.000 claims description 4
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 claims description 4
- YXVXMURDCBMPRH-UHFFFAOYSA-N Lirinidine Natural products C1C2=CC=CC=C2C2=C(O)C(OC)=CC3=C2C1N(C)CC3 YXVXMURDCBMPRH-UHFFFAOYSA-N 0.000 claims description 3
- ORJVQPIHKOARKV-UHFFFAOYSA-N Nuciferine Natural products C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2C1N(C)CC3 ORJVQPIHKOARKV-UHFFFAOYSA-N 0.000 claims description 3
- ORJVQPIHKOARKV-OAHLLOKOSA-N nuciferine Chemical compound C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2[C@@H]1N(C)CC3 ORJVQPIHKOARKV-OAHLLOKOSA-N 0.000 claims description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 3
- 235000013824 polyphenols Nutrition 0.000 claims description 3
- 235000013616 tea Nutrition 0.000 claims description 3
- 235000013305 food Nutrition 0.000 claims description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 abstract description 22
- 210000000577 adipose tissue Anatomy 0.000 abstract description 14
- 239000001259 polydextrose Substances 0.000 abstract description 11
- 229940035035 polydextrose Drugs 0.000 abstract description 11
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 abstract description 10
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 abstract description 10
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 9
- 238000010521 absorption reaction Methods 0.000 abstract description 8
- 230000015556 catabolic process Effects 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 3
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 abstract 2
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 241000700159 Rattus Species 0.000 description 16
- 235000019197 fats Nutrition 0.000 description 16
- 230000037396 body weight Effects 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 9
- 238000012360 testing method Methods 0.000 description 8
- 208000008589 Obesity Diseases 0.000 description 6
- 235000020824 obesity Nutrition 0.000 description 6
- 206010033307 Overweight Diseases 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 235000008098 Oxalis acetosella Nutrition 0.000 description 2
- 241001119526 Paullinia Species 0.000 description 2
- 235000010240 Paullinia pinnata Nutrition 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 210000001789 adipocyte Anatomy 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 235000019784 crude fat Nutrition 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000002468 fat body Anatomy 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 102100036264 Glucose-6-phosphatase catalytic subunit 1 Human genes 0.000 description 1
- 101710099339 Glucose-6-phosphatase catalytic subunit 1 Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000256856 Vespidae Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000011759 adipose tissue development Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000002956 ash Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 238000004900 laundering Methods 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000001853 liver microsome Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 208000001022 morbid obesity Diseases 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- -1 pulvis Substances 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F5/00—Coffee; Coffee substitutes; Preparations thereof
- A23F5/24—Extraction of coffee; Coffee extracts; Making instant coffee
- A23F5/36—Further treatment of dried coffee extract; Preparations produced thereby, e.g. instant coffee
- A23F5/40—Further treatment of dried coffee extract; Preparations produced thereby, e.g. instant coffee using organic additives, e.g. milk, sugar
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention discloses a composition with weight losing function. The composition consists of the following components in parts by weight 10-200 parts of green tea extract, 10-200 parts of green coffee bean extract, 20-200 parts of L-carnitine, 20-300 parts of arabinose, 0.5-50 parts of lotus leaf extract, and 200-2000 parts of polydextrose. The green tea extract, green coffee bean extract, L-carnitine, arabinose, lotus leaf extract, and polydextrose are blended in specific proportions. By the synergistic effects of the raw materials, the composition with weight losing function can accelerate the catabolism of body fat, inhibit the organism absorption of fat and sugar, and thus the effects of reducing body fat and losing weight are achieved.
Description
Technical field
The present invention relates to health product technology field, especially relate to a kind of composition and the application thereof with weight losing function.
Background technology
A up-to-date research report display, at present, the fat and overweight total population in the whole world has reached 2,100,000,000 people---close to total world population's 30%, in the population of being obese of state-owned 4,600 ten thousand people.Fat in close relations with health.Research shows, the severe obesity life-span obviously shortens, and the obesity of light, moderate also with the obvious rising of the death rate, and raises relevant with annual death rate morning.Manhood obesity is the strong predictive factor of senescence phase death.The chance that various diseases occurs overweight people increases.Medical research confirms, the independent hazard factor that obesity is coronary heart disease, hypertension, diabetes, cerebral apoplexy occur.Obesity has become one of the most important medical science of 21 century human society and public hygienics problem.
Overweight or obesity refers to that the fat constituent that caused by many reasons too much and exceed the pathological state of normal person's average magnitude.Overweight and obesity have h and E two aspect factor, be body control volume fat, the result that causes of the disorderly particularly sugar/disorders of lipid metabolism of energy metabolism balance mechanism.
Summary of the invention
The object of the invention is to provide a kind of composition with weight losing function, said composition has promotion energetic supersession, accelerates the catabolism of body fat, suppresses body to the absorption of fat and sugar class, the normal diet simultaneously not affecting people is movable, reaches effect of natural contral body weight.
To achieve these goals, the present invention is by the following technical solutions:
A kind of composition with weight losing function, the described composition with weight losing function is made up of the component of following weight portion: 10 ~ 200 parts of green-tea extracts, 10 ~ 200 parts of green coffee bean extracts, 20 ~ 200 parts of l-cns, 20 ~ 300 portions of arabinoses, 0.5 ~ 50 part of Lotus Leafextract, 200 ~ 2000 parts of polydextroses.Weight reducing compound of the present invention, carries out composite in specific proportions, and the green-tea extract in composition can suppress aliphatic acid to synthesize and lipocyte proliferation, promotes fat oxidation; Chlorogenic acid in green coffee bean extract is the specific inhibitor of liver microsomes G-6-Pase, suppresses the absorption of glycogen release and glucose; L-cn can promote the oxidation Decomposition of body fat, reduces accumulation of fat precipitation; Arabinose suppresses the activity of invertase in small intestine, reduces the absorption of small intestine to glucose and fructose; Lotus Leafextract promotes fat cell metabolism, reduces fat absorption, the fat that polydextrose suppresses lipolytic enzyme degraded to be taken in, and fat is digested in vivo and is obstructed, simultaneously with Adipogenesis compound along with ight soil excretes, reduce body to the absorption of fat.In the present invention, each component acts synergistically mutually, can accelerate the catabolism of body fat, suppresses body to the absorption of fat and sugar class, thus reaches the effect reducing body fat and fat-reducing.
As preferably, described in there is weight losing function composition be made up of the component of following weight portion: 50 ~ 100 parts of green-tea extracts, 50 ~ 100 parts of green coffee bean extracts, 50 ~ 100 parts of l-cns, 50 ~ 150 portions of arabinoses, 0.5 ~ 10 part of Lotus Leafextract, 600 ~ 1200 parts of polydextroses.
As preferably, described in there is weight losing function composition be made up of the component of following weight portion: 80 parts of green-tea extracts, 80 parts of green coffee bean extracts, 70 parts of l-cns, 100 portions of arabinoses, 1 part of Lotus Leafextract, 1000 parts of polydextroses.
As preferably, content >=40% of Tea Polyphenols in described green-tea extract; Content >=40% of total chlorogenic acid in described green coffee bean extract; Content >=2% of Nuciferine in described Lotus Leafextract.
A kind of application of composition in food or health products with weight losing function.
Therefore, the present invention has following beneficial effect: green-tea extract, green coffee bean extract, l-cn, arabinose, Lotus Leafextract, polydextrose carry out composite by the present invention in specific proportions, under the synergy of above-mentioned raw materials, the catabolism of body fat can be accelerated, suppress body to the absorption of fat and sugar class, thus reach the effect reducing body fat and fat-reducing.
Detailed description of the invention
Below by detailed description of the invention, the present invention will be further described.
The raw material that the present invention relates to can commercially availablely obtain, green-tea extract is purchased from Nuode Biological Ind Co., Ltd., Shanghai (40 ~ 98% Tea Polyphenols), green coffee bean extract is purchased from Zhejiang Skyherb Ingredients Co., Ltd. (40 ~ 60% total chlorogenic acid), l-cn is purchased from husky (China) Investment Co., Ltd of dragon, Lotus Leafextract is purchased from Kang Lu bio tech ltd, Hunan (2 ~ 80% Nuciferine), and polydextrose is purchased from Shanghai Bocheng Biotechnology Co., Ltd..
Embodiment 1
There is a composition for weight losing function, mixed by the component of following weight portion: 10g green-tea extract, the green coffee bean extract of 10g, 20g l-cn, 20g arabinose, 0.5g Lotus Leafextract, 200g polydextrose.
Embodiment 2
There is a composition for weight losing function, mixed by the component of following weight portion: 50g green-tea extract, the green coffee bean extract of 50g, 50g l-cn, 50g arabinose, 0.5g Lotus Leafextract, 600g polydextrose.
Embodiment 3
There is a composition for weight losing function, mixed by the component of following weight portion: 80g green-tea extract, the green coffee bean extract of 80g, 70g l-cn, 100g arabinose, 1g Lotus Leafextract, 1000g polydextrose.
Embodiment 4
There is a composition for weight losing function, mixed by the component of following weight portion: 100g green-tea extract, the green coffee bean extract of 100g, 100g l-cn, 150g arabinose, 10g Lotus Leafextract, 1200g polydextrose.
Embodiment 5
There is a composition for weight losing function, mixed by the component of following weight portion: 20g green-tea extract, the green coffee bean extract of 40g, 30g l-cn, 30g arabinose, 15g Lotus Leafextract, 800g polydextrose.
Embodiment 6
There is a composition for weight losing function, mixed by the component of following weight portion: 120g green-tea extract, the green coffee bean extract of 110g, 120g l-cn, 200g arabinose, 20g Lotus Leafextract, 1500g polydextrose.
The composition embody rule method with weight losing function of the present invention is: directly add in the desired amount in the preparation process of bread and cheese and health food, the formulation of bread and cheese and health food can be beverage, solid beverage, oral liquid, capsule, tablet, pulvis, granule etc., and its formulation is unrestricted.
Below by animal pharmacological test to prove actual effect of the present invention:
1, experiment material
Animal used as test: SPF male SD rat, body weight 200 ± 20g, purchased from Zhejiang Province's Experimental Animal Center.
2, test method
Dosage grouping and given the test agent give the time: a normal group, a dosage group and a model control group are established in experiment, and dosage is 30 times of human body recommended amounts.Given the test agent gives 7 weeks time.
High heat model feed: add 15.0% sucrose, 15.0% lard, appropriate casein, calcium monohydrogen phosphate, stone flour etc. in maintenance feed.Except crude fat, the moisture of model feed, crude protein, crude fat, crude fibre, coarse ash, calcium, phosphorus, calcium: phosphorus all will reach the national standard maintaining feed.
Experimental procedure: rat feeding maintains feed observation 5 ~ 7 days under barrier system, is divided into 2 groups at random after the laundering period terminates by body weight, 10 rats give to maintain feed as Normal group, and 30 rats give high heat model feed.Record weekly to appetite, berley amount, surplus appetite, weigh in 1 time.After feeding 2 weeks, 30 rats giving high-calorie feed are sorted by weight gain, the 1/3 Diet resistant rat that superseded weight gain is lower.Filter out 20 fat Sensitive Rats are divided into 2 groups at random by body weight, are respectively model group and medication group.Model control group and medication group give high heat model feed, and Normal group gives to maintain feed.Each dosage group gavage gives the given the test agent of various dose, and model control group and Normal group give the coordinative solvent of equivalent, and given the test agent gives 7 weeks time.Record weekly to appetite, berley amount, surplus appetite, weigh in 1 time.
After off-test, weigh, 1% yellow Jackets (0.5ml/100gBW) are anaesthetized, and solution takes perinephric fat, testis peripheral adipose, and weighs, and calculate fat/body ratio.
Data processing: all experimental datas all adopt mean ± standard deviation to represent, two groups are compared employing t inspection, data analysis adopts SPSS13.0 statistical analysis software, and p < 0.05 is that there were significant differences, and p < 0.01 is for there being pole significant difference.
3, result of the test
(1) Weight reducing compound is on the impact of rat body weight
From table 1 and table 2, model group rats body weight and body weight growth pole are significantly higher than Normal group (p < 0.01), and modeling success is described; And medication group rat body weight and body weight growth pole are significantly lower than model group control group (p < 0.01), illustrate that Weight reducing compound has the effect controlling body weight.
Table 1 Weight reducing compound is on the impact (unit: g) of rat body weight
Note: compare with Normal group, * * p < 0.01; Compare with model control group,
##p < 0.01.
Impact (the unit: g) that table 2 Weight reducing compound increases weight on rat body weight
Note: compare with Normal group, * * p < 0.01; Compare with model control group,
##p < 0.01.
(2) Weight reducing compound is on the impact of rat body fat weight
From table 3, model group rats body fat weight and fat body are significantly higher than Normal group (p < 0.01) than pole, and medication group rat body fat weight and fat body are than extremely remarkable in model group control group (p < 0.01), illustrate that Weight reducing compound has the effect reducing body fat.
Table 3 Weight reducing compound is on the impact of rat body fat weight
Note: compare with Normal group, * * p < 0.01; Compare with model control group,
##p < 0.01.
4, conclusion
Shown by above-mentioned experimental result, the composition with weight losing function of the present invention has the effect reducing body fat and fat-reducing.
Above-described embodiment is one of the present invention preferably scheme, not does any pro forma restriction to the present invention, also has other variant and remodeling under the prerequisite not exceeding the technical scheme described in claim.
Claims (5)
1. one kind has the composition of weight losing function, it is characterized in that, the described composition with weight losing function is made up of the component of following weight portion: 10 ~ 200 parts of green-tea extracts, 10 ~ 200 parts of green coffee bean extracts, 20 ~ 200 parts of l-cns, 20 ~ 300 portions of arabinoses, 0.5 ~ 50 part of Lotus Leafextract, 200 ~ 2000 parts of polydextroses.
2. a kind of composition with weight losing function according to claim 1, it is characterized in that, the described composition with weight losing function is made up of the component of following weight portion: 50 ~ 100 parts of green-tea extracts, 50 ~ 100 parts of green coffee bean extracts, 50 ~ 100 parts of l-cns, 50 ~ 150 portions of arabinoses, 0.5 ~ 10 part of Lotus Leafextract, 600 ~ 1200 parts of polydextroses.
3. a kind of composition with weight losing function according to claim 1, it is characterized in that, the described composition with weight losing function is made up of the component of following weight portion: 80 parts of green-tea extracts, 80 parts of green coffee bean extracts, 70 parts of l-cns, 100 portions of arabinoses, 1 part of Lotus Leafextract, 1000 parts of polydextroses.
4. a kind of composition with weight losing function according to claim 1 or 2 or 3, is characterized in that, content >=40% of Tea Polyphenols in described green-tea extract; Content >=40% of total chlorogenic acid in described green coffee bean extract; Content >=2% of Nuciferine in described Lotus Leafextract.
5. the application of the composition with weight losing function in food or health products as described in claim 1 or 2 or 3.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510523739.5A CN105146267A (en) | 2015-08-24 | 2015-08-24 | Composition with weight losing function and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510523739.5A CN105146267A (en) | 2015-08-24 | 2015-08-24 | Composition with weight losing function and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105146267A true CN105146267A (en) | 2015-12-16 |
Family
ID=54787663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510523739.5A Pending CN105146267A (en) | 2015-08-24 | 2015-08-24 | Composition with weight losing function and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105146267A (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106605744A (en) * | 2016-08-25 | 2017-05-03 | 西安源森生物科技有限公司 | Composition capable of reducing fat, slimming, expelling toxin and beautifying, as well as preparation method thereof |
| CN106962939A (en) * | 2017-04-11 | 2017-07-21 | 姜红成 | Prepare the fermentation composition and preparation method of the plant enzyme with weight-reducing degreasing effect |
| CN108095113A (en) * | 2017-12-22 | 2018-06-01 | 成都博创必成医药技术有限公司 | A kind of composition, preparation and its application with fat reducing blood sugar reducing function |
| CN108244643A (en) * | 2017-12-13 | 2018-07-06 | 北京康比特体育科技股份有限公司 | It is a kind of can management and control weight and lifter motion ability composition |
| CN109430867A (en) * | 2018-11-15 | 2019-03-08 | 通化特立杰尔医药技术推广服务有限公司 | A kind of enriching yin and nourishing kidney composition and the preparation method and application thereof |
| CN109567201A (en) * | 2019-01-04 | 2019-04-05 | 无锡海尔偲生命科技有限公司 | For blocking composition and the application of human body parts fat and carbohydrate absorption |
| CN110898178A (en) * | 2019-12-27 | 2020-03-24 | 张菊霞 | Weight-losing liniment |
| CN113975335A (en) * | 2021-12-29 | 2022-01-28 | 仙乐健康科技股份有限公司 | Composition for controlling appetite and inducing satiety |
| CN114404599A (en) * | 2022-01-11 | 2022-04-29 | 刘振宇 | Pure natural product composition capable of inhibiting L, D-transpeptidase and preparation method thereof |
| CN114632101A (en) * | 2022-03-10 | 2022-06-17 | 广东省科学院微生物研究所(广东省微生物分析检测中心) | Cordyceps guangdongensis weight-losing lipid-lowering liver-protecting compound for treating obesity and related syndromes as well as preparation method and application thereof |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007330124A (en) * | 2006-06-13 | 2007-12-27 | Kenko Tsusho Kk | Health food composition for preventing and ameliorating obesity and lifestyle-related disease |
| CN102366094A (en) * | 2011-09-22 | 2012-03-07 | 唐传生物科技（厦门）有限公司 | Fat-reducing and hypolipemic health food |
| CN103284039A (en) * | 2012-12-27 | 2013-09-11 | 福建永生活力生物工程有限公司 | Weight-reducing composition and preparation method thereof |
| CN103393762A (en) * | 2013-08-20 | 2013-11-20 | 苏州普纳斯电子有限公司 | Diet preparation |
| CN104138002A (en) * | 2014-08-05 | 2014-11-12 | 溧阳市天目湖保健品有限公司 | Health food with weight reducing function and preparing method of health food |
| CN104188037A (en) * | 2014-09-29 | 2014-12-10 | 天津市聚星康华医药科技有限公司 | Composite L-carnitine beverage |
| CN104688958A (en) * | 2015-03-18 | 2015-06-10 | 遵义陆圣康源科技开发有限责任公司 | Drug combination having function of losing weight |
-
2015
- 2015-08-24 CN CN201510523739.5A patent/CN105146267A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007330124A (en) * | 2006-06-13 | 2007-12-27 | Kenko Tsusho Kk | Health food composition for preventing and ameliorating obesity and lifestyle-related disease |
| CN102366094A (en) * | 2011-09-22 | 2012-03-07 | 唐传生物科技（厦门）有限公司 | Fat-reducing and hypolipemic health food |
| CN103284039A (en) * | 2012-12-27 | 2013-09-11 | 福建永生活力生物工程有限公司 | Weight-reducing composition and preparation method thereof |
| CN103393762A (en) * | 2013-08-20 | 2013-11-20 | 苏州普纳斯电子有限公司 | Diet preparation |
| CN104138002A (en) * | 2014-08-05 | 2014-11-12 | 溧阳市天目湖保健品有限公司 | Health food with weight reducing function and preparing method of health food |
| CN104188037A (en) * | 2014-09-29 | 2014-12-10 | 天津市聚星康华医药科技有限公司 | Composite L-carnitine beverage |
| CN104688958A (en) * | 2015-03-18 | 2015-06-10 | 遵义陆圣康源科技开发有限责任公司 | Drug combination having function of losing weight |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106605744A (en) * | 2016-08-25 | 2017-05-03 | 西安源森生物科技有限公司 | Composition capable of reducing fat, slimming, expelling toxin and beautifying, as well as preparation method thereof |
| CN106962939A (en) * | 2017-04-11 | 2017-07-21 | 姜红成 | Prepare the fermentation composition and preparation method of the plant enzyme with weight-reducing degreasing effect |
| CN108244643A (en) * | 2017-12-13 | 2018-07-06 | 北京康比特体育科技股份有限公司 | It is a kind of can management and control weight and lifter motion ability composition |
| CN108244643B (en) * | 2017-12-13 | 2021-06-04 | 北京康比特体育科技股份有限公司 | Composition capable of controlling weight and improving athletic ability |
| CN108095113A (en) * | 2017-12-22 | 2018-06-01 | 成都博创必成医药技术有限公司 | A kind of composition, preparation and its application with fat reducing blood sugar reducing function |
| CN109430867A (en) * | 2018-11-15 | 2019-03-08 | 通化特立杰尔医药技术推广服务有限公司 | A kind of enriching yin and nourishing kidney composition and the preparation method and application thereof |
| CN109567201A (en) * | 2019-01-04 | 2019-04-05 | 无锡海尔偲生命科技有限公司 | For blocking composition and the application of human body parts fat and carbohydrate absorption |
| CN110898178A (en) * | 2019-12-27 | 2020-03-24 | 张菊霞 | Weight-losing liniment |
| CN113975335A (en) * | 2021-12-29 | 2022-01-28 | 仙乐健康科技股份有限公司 | Composition for controlling appetite and inducing satiety |
| CN113975335B (en) * | 2021-12-29 | 2022-04-08 | 仙乐健康科技股份有限公司 | Composition for controlling appetite and inducing satiety |
| CN114404599A (en) * | 2022-01-11 | 2022-04-29 | 刘振宇 | Pure natural product composition capable of inhibiting L, D-transpeptidase and preparation method thereof |
| CN114632101A (en) * | 2022-03-10 | 2022-06-17 | 广东省科学院微生物研究所(广东省微生物分析检测中心) | Cordyceps guangdongensis weight-losing lipid-lowering liver-protecting compound for treating obesity and related syndromes as well as preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105146267A (en) | Composition with weight losing function and application thereof | |
| CN100998650A (en) | Use of cinnamonum cassia for treating diabetes, its products and preparing method | |
| WO2011077800A1 (en) | Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages | |
| JP2023538664A (en) | Compositions of ginsenoside Rg3 and ginsenoside Rg5 and their pharmaceutical uses, including antitumor effects | |
| CN105031041A (en) | PLANT EXTRACT COMPOSITION, and pharmaceutical COMPOSITION and APPLICATION THEREOF | |
| CN105530928A (en) | Anti-obesity composition containing lycium chinense miller leaf extract powder and betaine as active ingredients | |
| KR20120002131A (en) | Composition for treating or preventing obesity containing curcuma longa extract | |
| KR20120003693A (en) | Anti-obesity composition comprising red grape extracts, green tea extracts, soybean extracts, and l-carnitine | |
| CN106036898A (en) | Composition having anti-fatigue effects and preparation method and use thereof | |
| Hosseini et al. | A comparative study of the effect of Kombucha prepared from green and black teas on the level of blood glucose and lipid profile of diabetic rats. | |
| KR20160141027A (en) | Phamaceutical composition or healthy food comprising water extracts from Pleurotus eryngii var. ferulea (Pf.). for treating or preventing metabolic disorder | |
| CN108420890B (en) | Composition with blood fat reducing effect and preparation method thereof | |
| KR20140086210A (en) | Composition comprising tetrandrine for treating obesity-induced inflammation | |
| CN103610051A (en) | Food, healthcare food or medicine composition with lipid-lowering effect as well as preparation methods and applications thereof | |
| WO2019100843A1 (en) | Enteromorpha prolifera polysaccharide composite blood lipid-lowering health care product and preparation method therefor | |
| KR101851639B1 (en) | Composition for anti-obesity comprising Chaenomelis Fructus extract or its fraction as effective component | |
| KR20200022660A (en) | Composition for preventing or treating of fatty liver, hyperlipemia or obesity comprising mixed extracts | |
| WO2015188428A1 (en) | 一种应用于治疗代谢综合征的药物 drug for treating metabolic syndrome | |
| KR102055879B1 (en) | Composition comprising ecklonia cava extract for dietary control and manufacturing method thereof | |
| CN114711296A (en) | Medicinal and edible cow milk formula milk powder capable of reducing blood pressure and preparation method of medicinal and edible cow milk formula milk powder | |
| CN109364202B (en) | Composition and preparation method and application thereof | |
| CN103156188A (en) | Health food with function of immune regulation and hypoxia tolerance | |
| US20220062312A1 (en) | Oral composition comprising b-escin and the use thereof | |
| CN105361171A (en) | Composition with physical fatigue-relieving effect | |
| CN102599312B (en) | Oligosaccharide Panax notoginseng sweet tea and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151216 |